
    
      a prospective randomized controlled, open-labeled study in patients with Diabetes nephropathy

        -  Arm 1: Valsartan + Probucol Valsartan (160mg/day) + Probucol (750mg/day)

        -  Arm 2: Valsartan + Placebo Valsartan (160mg/day) + Placebo
    
  